Using mobile health tools to improve oral chemotherapy adherence in young cancer patients
Using Real Time Mobile Health Approaches to Understand and Promote Oral Chemotherapy Adherence in Adolescents and Young Adults with Leukemia
This study is all about helping teenagers and young adults with leukemia stick to their oral chemotherapy by using mobile apps to track how they're feeling and send them helpful reminders and support messages.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10688202 on NIH RePORTER |
What this research studies
This research focuses on improving adherence to oral chemotherapy among adolescents and young adults with leukemia by utilizing real-time mobile health technologies. The study will track daily factors that influence medication adherence, such as fatigue and motivation, through mobile assessments involving both patients and their caregivers. Additionally, it aims to create personalized mobile interventions that send timely reminders and support messages to encourage consistent medication intake. By addressing the barriers to adherence, the research seeks to enhance treatment outcomes for this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults diagnosed with leukemia who are prescribed oral chemotherapy, specifically 6-mercaptopurine.
Not a fit: Patients who are not undergoing treatment with oral chemotherapy or those outside the adolescent and young adult age range may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment adherence and outcomes for adolescents and young adults with leukemia.
How similar studies have performed: Previous research has shown promise in using mobile health interventions to improve medication adherence in various populations, indicating potential success for this approach.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Psihogios, Alexandra — Northwestern University at Chicago
- Study coordinator: Psihogios, Alexandra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.